Jazz Pharmaceuticals Comprehensive Income 2010-2024 | JAZZ

Jazz Pharmaceuticals comprehensive income for the quarter ending September 30, 2024 was $-0.603B, a 41.72% decline year-over-year.

  • Jazz Pharmaceuticals comprehensive income for 2023 was $-0.842B, a 25.18% decline from 2022.
  • Jazz Pharmaceuticals comprehensive income for 2022 was $-1.126B, a 181.12% increase from 2021.
  • Jazz Pharmaceuticals comprehensive income for 2021 was $-0.4B, a 197.99% increase from 2020.

Jazz Pharmaceuticals Comprehensive Income 2010-2024 | JAZZ

  • Jazz Pharmaceuticals comprehensive income for 2023 was $-0.842B, a 25.18% decline from 2022.
  • Jazz Pharmaceuticals comprehensive income for 2022 was $-1.126B, a 181.12% increase from 2021.
  • Jazz Pharmaceuticals comprehensive income for 2021 was $-0.4B, a 197.99% increase from 2020.